Media & Analysis
3 Q&A interviews with MVA-membersContact person
3 Q&A Interview with Torben Thers Nørgaard General Manager, Cencora Pharmalex Nordic
Q1) What do you think are the most unique characteristics of the Medicon Valley life science cluster and the life science in Denmark and Sweden as such? Medicon Valley is the heart of Nordic life science. Positioned strategically between Scandinavia and the rest of Europe, Medicon Valley offers...
3 Q&A Interview with Shahin Hojjati, Regional Sales Manager Biotech Benelux & Nordics, Fisher Scientific
1) What do you consider the most relevant must-win challenge for your part of the life science industry? Our primary focus is ensuring that our customers not only view us as their preferred supplier for lab supplies but also as a strategic partner dedicated to optimizing their workflows. Beyond...
3 Q&A Interview with Anders Thelborg, General Manager at MVA-member, Bristol-Myers Squibb
1) Why has BMS as a global life science company decided to co-fund and establish a life science entrepreneurship course at KU? In 2016, Bristol Myers Squibb Denmark, the Danish Foundation for Entrepreneurship, and the University of Copenhagen (Faculty of Health and Medical Sciences) decided to...
3 Q & A Interview with Dr. Thomas Pfeuffer, Manager Business Development API and Richa Foster-Jones – Area Sales Director, new MVA-member, Fareva
1) What brought you to MVA? Our decision to join MVA stems from the recognition that while Fareva has established valuable partnerships in the Nordics, there is still room for increased visibility and engagement within the region. Despite our existing relationships with both start-ups and...
3 Q&A Interview with Director, Gitte Grønlund-Møller, MVA-member, Workindenmark
1) Who is Workindemark? Workindenmark is part of the Danish Agency for Labour Market and Recruitment (STAR), under the Ministry of Employment. Workindenmark is a public service to all Danish companies looking for qualified international employees. We guide the companies to their next employee...
3 Q&A interview with CEO Annette Säfholm, new MVA member Gedea Biotech
1) What are the key objectives for Gedea Biotech for the forseeable future? There is a lot going on at Gedea! Right now, we have two clinical trials running for our lead product pHyph; one in bacterial vaginosis and one for vaginal fungal infection. We anticipate the results by the end of this...
3 Q&A Interview with Dr. Efstathios Vassiliadis, CEO new MVA-member Evnia
Q1: What do you consider the key barriers to accelerate innovation in the medical device industry? In the current complex regulatory environment, especially in EU, under Medical Device Regulation, poor regulatory decisions and clinical strategy can have a detrimental effect on both the time and...
3 Q&A Interview with Carlos Claro, Senior Vice President of new MVA-member, CIBT / Blair Consular
Q1: With CIBT / Blair Consular Services already serving many clients within Medicon Valley, what prompted the decision to join the Medicon Valley Alliance? Joining the Medicon Valley Alliance was a strategic move driven by our desire to deepen our engagement with the life science industry. We...
3 Q&A Interview with Anders Almgren, mayor of MVA-member, City of Lund
1) What is the vision behind Lund Innovation District? The Vision is “Global impact within walking distance”. A well-functioning ID is a cornerstone for Lund as an internationally recognized innovation hub. It is a place where unique developments take place, attracting international actors and...
3 Q& A Interview with MVA-member ProPharma Group President Jason DeGoes
Q1: Being an American company, how did you first learn about the Medicon Valley cluster? ProPharma Group is headquartered in the US, but we are very much a global organization, and our Sweden-based team has been supporting the needs of our Pharma, Biotech and Medical Device customers in the...